Tema Oncology ETF (CANC)
NasdaqGM: CANC
· Echtzeitkurs · USD
42.55
-0.59 (-1.37%)
Zum Schluss: Aug 13, 2026, 3:58 PM
42.71
+0.38%
Nachbörslich: 7:34 PM
Tema Oncology ETF (CANC) ETF Price, Holdings & Analysis
-1.37% (1D)
| Geld | 41.61 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 193.31 Mio |
| NAV | 43.08 |
| Beta | k.A. |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 26.76 |
| Ausstehende Anteile | k.A. |
| Auflagedatum | Aug 14, 2023 |
| Brief | 42.11 |
| Volumen | 18,707 |
| Ø Vol. (20D) | 32,104 |
| Eröffnung | 43.51 |
| Vortagesschluss | 43.14 |
| Tagesspanne | 42.36 - 43.51 |
| 52-Wk Range | 26.24 - 43.51 |
| Positionen | k.A. |
| Kostenquote | 0.75% |
Über CANC
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Anlageklasse Equity
Tickersymbol CANC
Auflagedatum Aug 14, 2023
Anbieter Tema Etfs
Website Fonds-Homepage
Börse NasdaqGM
Top 10 Positionen 42.56% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Revolution Medicines... | RVMD | 6.14% |
| Cogent Biosciences I... | COGT | 5.31% |
| Eli Lilly And Co | LLY | 5.22% |
| Roche Holding Ag Adr | RHHBY | 4.65% |
| Novartis Ag Register... | NOVN.SW | 4.16% |
| Bristol-myers Squibb... | BMY | 3.73% |
| Abbvie Inc | ABBV | 3.72% |
| Merck & Co Inc | MRK | 3.65% |
| Johnson & Johnson | JNJ | 3.13% |
| Immunome Inc Ordinar... | IMNM | 2.85% |
Dividenden Dividendenrendite 0.05%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Dec 10, 2025 | $0.0200 | k.A. |
| Dec 11, 2024 | $0.7280 | k.A. |
| Dec 13, 2023 | $0.1490 | k.A. |
